glp-1 news today 2025 november 5 Lilly, chasing Novo, expects second-quarter FDA decision on obesity pill GLP-1 Pipeline Update: August 2025

10.1042/bst0311133 26 EelenG.de ZeeuwP.TrepsL.HarjesU.WongB

Design and discovery of mushroom tyrosinase inhibitors and their therapeutic applications

Patients experiencing sleep disturbances while taking tirzepatide can implement several strategies to improve sleep quality without discontinuing beneficial therapy

Oral Wegovy, offering similar efficacy as its injectable counterpart, and Foundayo, recognized for its flexible intake options, bring convenience to the realm of GLP-1 weight loss medications

Please monitor your weight to make sure youre staying in a healthy range

FDA has documented over 1000 adverse event reports linked to compounded versions of semaglutide and tirzepatide